Risk–benefit analysis of COVID-19 vaccines — a neurological perspective
Colleen L. Lau, Ian Galea
Topics & Concepts
Coronavirus disease 2019 (COVID-19)VaccinationPerspective (graphical)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Intensive care medicineMedicinePandemicGlobal healthRisk analysis (engineering)Computer scienceVirologyPublic healthArtificial intelligenceOutbreakPathologyDiseaseInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchPeripheral Neuropathies and DisordersHeparin-Induced Thrombocytopenia and Thrombosis